Elizabeth N. Pearce, MD, MSc

Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a DPP-IV inhibitor, according to findings published in Thyroid.

Women with subclinical hypothyroidism during the first half of pregnancy are more likely to develop overt hypothyroidism 5 years after delivery than women with hypothyroxinemia, according to a study published in Thyroid.

Just over a century ago, much of the U.S. population experienced disfiguring and debilitating disorders related to iodine deficiency. In 2024, we celebrate 100 years of salt iodization — a tremendous public health achievement.

Exposure to a class of endocrine-disrupting chemicals may increase the risk for developing thyroid cancer, according to a study published in eBioMedicine.

Exposure to some types of endocrine-disrupting chemicals may lead to alterations in thyroid function for reproductive-aged women, according to a study published in Toxics.

Overtreatment of adults with low risk differentiated thyroid cancer is more common using the 2015 Dutch Thyroid Cancer guideline compared with the American Thyroid Association’s guideline, according to study findings.

Future COVID-19 vaccination doses are safe for adults who previously had a COVID-19 vaccine-induced subacute thyroiditis, according to study data published in The Journal of Clinical Endocrinology & Metabolism.

A cohort of euthyroid individuals with Hashimoto’s thyroiditis were more likely to eat meat and less likely to adhere to a Mediterranean diet than healthy controls, according to findings published in Thyroid.

Adults in China with type 2 diabetes had improved glucose control and a restoration of thyroid function after participating in metabolic management, according to a study published in the Journal of Diabetes.

A 39-year-old woman, G5P2, initially presented for a routine prenatal visit at 12 weeks gestational age. Serum thyroid function tests obtained as part of her evaluation were thyroid stimulating hormone (TSH) 4) 3.42 ng/dL (normal 0.89 - 1.80 ng/dL).